INTRODUCTION
============

Oral cancer is 1 of the 10 most common cancers in the world.^[@R1]^ Its incidence has been rising not only in Asian countries such as Taiwan where betel nut consumption is high but also now in Western countries.^[@R2],[@R3]^ Oral cancer makes up for 70% of all head and neck cancers in Taiwanese males, and has been ranked fourth in incidence and mortality in that population since 1995. Treatment of this disease amounted to US\$1195 million in Taiwan in 2004. These expenditures are expected to increase dramatically in this decade, making oral cancer treatment a serious socioeconomic problem for a country that provides national health insurance (NHI) and an important public health issue.

An initial diagnosis of advanced-stage oral cancer carries with it a 35% chance of being cured.^[@R4]^ As the disease progresses, there is a concomitant increase in physical distresses and functional challenges. Although there are many different treatment options available to help relieve uncontrolled suffering of oral cancer at end-of-life (EOL), there is a paucity of information regarding the prognosis of this disease, treatment modalities, and the possible complications of medical care.^[@R5],[@R6]^ This makes proper EOL treatment decision making very difficult.

Previous studies from around the world have reported increasing aggressiveness in treatment for cancer near EOL, including increases in chemotherapy, hospital stay, intensive care unit (ICU) admission, emergency room (ER) visits, and deaths during acute care hospitalizations.^[@R7]--[@R10]^ In many instances, not only these treatments do *not* cure disease but they are also performed at high cost and compromise the quality of life of the patient close to death.^[@R11]^ These studies, however, focus on the impact of aggressive EOL treatment for all cancers, not on oral cancer, which is now on the increase outside of Asia.

This study uses the nationwide claims data from Taiwan\'s National Health Insurance Research Database (NHIRD) for patients who died from oral cancer between 2009 and 2011 to investigate the determinants of aggressive medical care for patients with oral cancer near death. This database provides basic demographic data as well as socioeconomic status (SES), disease severity, medical services, hospital characteristics, and hospital stay data.

METHODS
=======

Ethics Statement
----------------

This study was approved by the Institutional Review Board of Buddhist Dalin Tzu Chi General Hospital, Taiwan. Review board requirements for written informed consent were waived because all personal identifying information was removed from the data set prior to analysis.

Database
--------

We first accessed the National Register of Deaths Database to identify 5386 patients who died from oral cancer from 2009 to 2011. We then collected individual patient-level data for this study from Taiwan\'s NHIRD for the years 2009 to 2011. This data set is organized and managed by Taiwan\'s National Health Research Institutes but collected by Taiwan\'s NHI program, which has been in place in Taiwan since 1995. The program covers approximately 99% of the residents in Taiwan and has contracts with 97% of the medical providers there.^[@R12]^ To verify accuracy of diagnosis, Taiwan\'s Bureau of National Health Insurance randomly reviews the charts of 1 per 100 ambulatory and 1 per 20 inpatient claims and interviews patients.^[@R13],[@R14]^ Taiwan\'s NHI program is a single-payer system with the government as sole insurer and provides universal insurance coverage for comprehensive array of medical services for all of Taiwan\'s residents. Patients have free access to any medical care provider they choose as long as that provider has a contract with the Bureau of National Health Insurance.

Measurement
-----------

### Aggressiveness of EOL Care

This study adopted the 6 indicators of aggressiveness of EOL care from Earle et al.^[@R7],[@R15]^ These 6 indicators were use of chemotherapy, more than 1 ER visit, more than 1 hospital admission, more than 14 days of hospitalization, an ICU admission, and death in acute care hospital, all within the last month of life. Data for all of these indicators could be collected from Taiwan\'s NHIRD, which maintains records for all inpatient or outpatient claims for the last month of life. Regardless of whether a patient was enrolled in hospice home care or inpatient hospice services in the last month of life, hospitalization was not counted as aggressive care. Each person who died from oral cancer received a score of 1 point per indicator. With a total of 6 indicators, the composite score for each person ranged from 0 to 6, with higher scores indicating more aggressive EOL care.

### Patient Demographics

Patient characteristics included age, gender, postdiagnosis survival time, geographic location, urbanization level of residence, individual SES, cancer metastatic status, and severity of comorbidity. The recoding and definition of SES and urbanization of residence was mentioned in our previous study.^[@R16]^ Severity of comorbidity was based on the modified Charlson Comorbidity Index Score recorded on the claims database for the last 6 months of each patient\'s life. The Charlson Comorbidity Index Score is a widely accepted scale used for risk adjustment in administrative claims data sets.^[@R17]^ Oral cancer metastatic status was identified by International Classification of Diseases, Ninth Revision, codes 196.xx to 199.xx.

### Primary Physician\'s Specialty and the Characteristics of the Primary Hospital

The primary physician\'s specialty was identified from NHI claims and was dichotomized into oncologist versus other. The hospitals were categorized by hospital level (medical center, regional, or district hospital), caseload volume (high, medium, or low), and hospital spending intensity (high, medium, or low). The hospital caseload volume was sorted by their total patient volume using unique hospital identifiers reported in a previous study.^[@R18]^ The hospital spending index used in this study was based on the hospital EOL expenditure index, defined as the mean spending of hospitalization of patients in their last 6 months of life, modified from previous literature.^[@R19]^

Statistical Analysis
--------------------

All statistical operations were performed using SPSS (version 15; SPSS Inc, Chicago, IL). The impact of each explanatory variable on the aggressiveness of EOL care tool was examined by multivariate analysis using a random-intercept model, which accounts for patient clustering within hospitals and the continuous nature of the composite score for EOL care. A hospital-level random effect can account for possible correlations between EOL care within a hospital\'s panel because of hospital policies, facilities, or physician compensation mechanisms that are unique to a particular hospital. A 2-tailed value of *P* \< 0.05 was considered significant.

RESULTS
=======

A total of 5386 patients who died from oral cancer from 2009 to 2011 were identified in the National Register of Deaths Database. As can be seen in Table [1](#T1){ref-type="table"}, which shows a summary of patient characteristics, mean age at death was 57 ± 13 years. The majority (72.5%) of patients who died from oral cancer were between 35 and 64 years old. Most (64%) also had metastatic disease. Among the decedents with oral cancer, almost 30% died within 6 months after diagnosis. In the last month of life, 15.4% of these patients were treated by oncologists.

###### 

Baseline Characteristics
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As can be seen in Figure [1](#F1){ref-type="fig"}, which shows a line graph depicting distribution of aggressive EOL care indicators over 3 years, the mean composite score for aggressiveness of EOL care was 2.68 ± 1.37 with most oral cancer patients (96.1%) having at least 1 indicator of aggressive EOL care (Table [2](#T2){ref-type="table"}). In the majority of these patients, there was an increase in frequency of ER visits and ICU admissions in the last month of life in 2010 and 2011 compared with that in 2009. Besides, only 644 (12%) patients enrolled in hospice services in the last month of life.

![Trends for the 6 indicators of aggressive EOL care for Taiwanese patients who died from oral cancer from 2009 to 2011. EOL = end-of-life, ER = emergency room, ICU = intensive care unit.](medi-94-e460-g002){#F1}

###### 

Trends in Aggressive End-of-Life Care for Taiwanese Patients Who Died From Oral Cancer From 2009 to 2011
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Compared with the composite aggressive EOL care scores of 2009, those of 2010 and 2011 were not significantly higher (*P* = 0.150 and 0.626, respectively), after controlling for other variables (Table [3](#T3){ref-type="table"}). EOL care was found to be less aggressive for oral cancer patients who belonged to a high SES, who were older than 85 years, who resided in rural areas, who were primarily cared for by oncologists, and who had postdiagnosis survival times shorter than 6 months. It was found to be significantly more aggressive for those with higher levels of comorbidity and disease with metastasis (both *P* \< 0.001). Aggressiveness of EOL care was not found to be influenced by gender, geographic region, or hospital characteristics, which included hospital level, hospital spending intensity, and caseload volume.

###### 

Determinants of Aggressive End-of-Life Care for Taiwanese Patients Who Died From Oral Cancer From 2009 to 2011 by Multivariate Analysis Using a Random-Intercept Mode
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DISCUSSION
==========

In this study tapping Taiwan\'s NHIRD claims records for patients who died from oral cancer between 2009 and 2011, it was found that 96.1% of those patients who died from this disease between 2009 and 2011 had at least 1 of the 6 indicators of aggressive care (forms of aggressive treatment) near the EOL used by Earle et al,^[@R7],[@R15]^ and that composite aggressive EOL care scores for 2010 and 2011 were not significantly higher than those found in 2009 (*P* = 0.150 and 0.626, respectively). There was a high utilization rate in chemotherapy, ER visits, and ICU admissions in the last month of life in more than 50% of these oral cancer patients.

The finding of tendency toward aggressiveness of care at EOL is consistent with those of earlier studies investigating aggressive EOL care and cancer death, although none studied oral cancer specifically.^[@R7]--[@R10]^ Those studies reported this trend to be increasing over time, but not seen in our result. Similar to previous reports,^[@R7]--[@R10],[@R20],[@R21]^ we found that patients who were elderly (≧85 years), who had lower level of comorbidity indices, who had no distant metastasis, or who were living in the rural area were less likely to receive aggressive EOL treatment. Our findings differ from previous findings first with regard to the impact of variables on aggressiveness of EOL care in our study population. Earle et al,^[@R7],[@R8]^ Tang et al,^[@R9]^ Ho et al,^[@R10]^ Saito et al,^[@R20]^ and Warren et al^[@R22]^ found that cancer patients who were male gender, who were primarily cared for by oncologists, who had higher-level individual SES, who had shorter postdiagnosis survival time, or who were treated in teaching hospitals were more likely to have 1 or more indicators of aggressive EOL care (eg, chemotherapy, ICU utilization, ER visits). Residence region was also a significant independent predictor of intensive EOL care in those studies. However, in our study of oral cancer patients, aggressiveness of EOL care was not influenced by sex, hospital teaching level, and residence area, and patients who had higher-level individual SES, who had shorter postdiagnosis survival times (\<6 months), or who were treated by oncologists had lower composite aggressive EOL care scores. The reason may be due to poor prognosis of advanced-stage oral cancer that has not shown any significant improvement over the past few decades.^[@R23]^ Diseases have generally been treated much less aggressively if they were considered highly fatal.^[@R24]^ Previous studies did not investigate the relation between hospital spending and hospital caseload volume. We did, but found no significant difference with regard to the influence of these variables and aggressiveness of EOL care. Tang et al, studying a cohort of patients who died from cancer in Taiwan from 2001 to 2006, found that from 10% to 20% of cancer patients near death received chemotherapy, were admitted to ICUs, or had emergency department visits.^[@R9]^ However, we found that more than 50% of oral cancer patients near death were admitted to ICUs and had emergency department visits and almost 70% received chemotherapy in the last month of life. Our results suggest that physicians may have more aggressive attitude toward EOL treatment and provide more intensive treatment for oral cancer patients than for other cancer patients.

More than half of the oral cancer patients we studied had distant metastasis near death. Platinum-based chemotherapy in combination with cetuximab and taxane has been found to improve survival of head and neck cancer patients with distant metastasis.^[@R25]--[@R28]^ Therefore, it is not surprising that the oral cancer patients in our study had a higher rate of chemotherapy (\>70%), although current salvage chemotherapy regimens may prolong life by a matter of months only and have response rates below 50%. Furthermore, platinum- or taxane-based chemotherapy was associated with significant comorbidity, including pancytopenia, nausea, vomiting, stomatitis, and renal toxicity.^[@R29]^ Oral surgeons may fear that they have not done enough in terms of surgery, chemotherapy, or radiotherapy, and may not pay as much attention to the possibility that they have done too much and adversely affected patients' quality of life. Although symptoms related to oral cancer progression may require acute care utilization, the adverse effects of chemotherapy would result in increased numbers of ER visits, ICU admissions, and cases of unexpected toxic complications, which obviously affect quality of life and interfere with preparation for death.^[@R30]^

Physicians tend to overestimate survival time for terminal cancer patients.^[@R31]^ They may also feel more comfortable suggesting alternate aggressive treatment goals rather than bringing up the topic of impending death, breaking bad news, and suggesting palliative care.^[@R6]^ Shifting to third- or fourth-line chemotherapy may be an easier topic to discuss than hospice care. Avoiding the topic or withholding detailed prognostic information can lead to patient mistrust of the health care system and medical profession, inappropriate use of life-sustaining medical treatments, increased medical complications, and long hospital stays.^[@R32]^ It seems as though physicians give the least honest figures to those with the worst prognoses, often creating unrealistic expectations regarding the potential success of aggressive treatment and interfering with their patients' rights to autonomy and self-determination.^[@R33]^ A positive association has been found between early EOL discussions and decision to accept less aggressive care.^[@R34]^

However, it is not all in the hands of the physicians, since even after the most frank communications regarding impending death, the patients, themselves, may hold unrealistic expectations and decide to continue chemotherapy.^[@R5]^ They may feel that doing something is better than doing nothing. Patients may also associate "palliative care\" or "hospice care\" with abandonment, an unpleasant emotion that many would prefer to avoid. Avoidance of this emotion can be achieved by distracting themselves with further treatments. Chen et al proposed exploring the subtypes of aggressive EOL care and the potential care quality problems could be better understood in each subtype.^[@R35]^ They classified patients who died from cancer into 3 subgroups based on the usage of aggressive EOL care, such as "not aggressive,\" "intent to sustain life,\" and "symptom crisis\" group. Thirty-three percent patients who died from cancer were in the "intent to sustain life\" subgroup, which was less likely to have metastatic disease and to receive hospice care in the EOL, but more likely to be cared for by nonmedical oncologists, to die within 2 months after diagnosis, and to die in hospital. Besides, the authors also found that the proportions of chemotherapy were similar among 3 subgroups. Chemotherapy for the terminally ill cancer patients was regarded as curative treatment rather than palliative treatment.

Policy Implications
-------------------

Taiwan\'s health system is closely intertwined with its NHI program, which covers the health care of almost all of its residents. This universal health insurance program is indeed very costly and takes up much of the nation\'s resources. Therefore, the problem of unnecessary or unrealistic aggressive treatment is also relevant. Increased aggressiveness translates into great economic burden.^[@R36],[@R37]^ In our study, only 12% of oral cancer patients enrolled in hospice services in the last month of life. The more time spent on aggressive EOL care, the less time spent on hospice care. The shorter the time spent in hospice care, the less opportunity for realizing EOL care goals of life closure, comfortable dying, and effective grieving.^[@R38]^ Hospices provide comprehensive, high-quality care that eases oral cancer patients' symptoms and prepares individuals and families for death. In a study of lung cancer patients with metastatic disease, Temel et al suggest that early palliative care can lead to significant improvements in quality of life, mood, and as much as 2 extra months of survival.^[@R39]^ Therefore, clinical and health policies might reduce focus on aggressive care when it will not benefit patients in favor of a more humanistic focus on patient comfort as well as more economic hospice care.

In fact, many terminally ill patients prefer home care, because they can be surrounded by their loved ones and minimize costs.^[@R40]^ There are, however, substantial disparities in access to hospice services.^[@R41]^ Tang et al have reported that less than one-third of patients who die from cancer receive hospice care at home in Taiwan.^[@R42]^ Therefore, it might be wise for the relevant authorities to encourage equanimity in availability of hospice care and provide more support for the training of hospice care providers.

Limitations of the Study
------------------------

This study has several limitations. One limitation is that the diagnosis of cancer and any comorbidity was completely dependent on International Classification of Diseases codes. There might have been some misclassification, although Taiwan\'s Bureau of National Health Insurance randomly reviews the chart and interviews patients in order to verify diagnostic accuracy.^[@R13],[@R14]^ Another limitation was that we could not use the claims database to evaluate satisfaction and quality of life in oral cancer patients. Still another limitation is the lack of detailed information about hospitalizations for diagnostic workup and chemotherapy for reducing symptoms among oral cancer patients in the last month of life. It would be overestimated if those hospitalizations and chemotherapy were considered as aggressive treatment at the EOL. However, given the robustness of the evidence and statistical analysis in this study, these limitations are unlikely to compromise our results.

CONCLUSION
==========

In summary, this study found that oral cancer patients who were younger in age, who had more comorbidity or metastasis, who belonged to a lower-level individual SES, who were primarily cared for by nononcologists, who had longer postdiagnosis survival times, or who resided in urban areas were more likely to receive more aggressive care at EOL. Oral cancer patients near death were also observed to have a far higher utilization rate of chemotherapy, ER services, and ICU services than other cancer patients near death. Future research may be needed to examine the effect of these 3 indicators on survival, quality of life, and medical costs.

Abbreviations: EOL = end-of-life, ER = emergency room, ICU = intensive care unit, NHIn = ational health insurance, NHIRD = National Health Insurance Research Database, SES = socioeconomic status.
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